⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tasigna

Every month we try and update this database with for tasigna cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER StudyNCT01657604
Chronic Myeloid...
Peginterferon α...
Nilotinib
18 Years - University of Jena
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform NeurofibromasNCT01275586
Neurofibromatos...
NF1
Neurofibromas
Tasigna
18 Years - Indiana University
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary CancerNCT05185947
Gynecologic Can...
Gynecologic Neo...
Peritoneal Carc...
Peritoneal Neop...
Ovarian Cancer
Ovarian Neoplas...
Colorectal Canc...
Colorectal Neop...
Appendiceal Can...
Appendiceal Neo...
Paclitaxel
Nilotinib
18 Years - National Institutes of Health Clinical Center (CC)
Evaluation of Efficacy and Safety of Nilotinib in Combination With Chemotherapy in Elderly Patients With Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaNCT01528085
Philadelphia Ch...
Nilotinib
55 Years - Goethe University
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER StudyNCT01657604
Chronic Myeloid...
Peginterferon α...
Nilotinib
18 Years - University of Jena
Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)NCT01261429
Pigmented Villo...
Tasigna
18 Years - Centre Leon Berard
Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)NCT01261429
Pigmented Villo...
Tasigna
18 Years - Centre Leon Berard
Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)NCT01270893
Gastrointestina...
Nilotinib
18 Years - M.D. Anderson Cancer Center
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of NilotinibNCT01223898
Chronic Myeloid...
Tasigna
18 Years - Novartis
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform NeurofibromasNCT01275586
Neurofibromatos...
NF1
Neurofibromas
Tasigna
18 Years - Indiana University
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.NCT01844765
Philadelphia Po...
nilotinib
1 Year - 17 YearsNovartis
Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)NCT01261429
Pigmented Villo...
Tasigna
18 Years - Centre Leon Berard
An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib TreatmentNCT00980018
Chronic Myeloge...
Nilotinib
18 Years - Novartis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: